ProCE Banner Activity

Lessons From Lockdown: Viral Hepatitis Testing and Treatment in the COVID-19 Era—Audio Recap

Podcast Episodes
In this engaging dialogue, 2 expert hepatologists discuss strategies for improving linkage to care of patients with viral hepatitis despite the challenges posed by the COVID-19 pandemic.

Released: March 14, 2022

Expiration: March 13, 2023

Share

Faculty

Jordan J. Feld

Jordan J. Feld, MD, MPH

Assistant Professor of Medicine
University of Toronto
Hepatologist
Toronto Centre for Liver Diseases
Sandra Rotman Centre for Global Health
Toronto, Ontario, Canada

Nancy Reau

Nancy Reau, MD

Associate Professor of Medicine
Center for Liver Disease
University of Chicago
Chicago, Illinois

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Educational grants provided by:

AbbVie

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Jordan J. Feld, MD, MPH

Assistant Professor of Medicine
University of Toronto
Hepatologist
Toronto Centre for Liver Diseases
Sandra Rotman Centre for Global Health
Toronto, Ontario, Canada

Jordan J. Feld, MD, MPH, has disclosed that he has received consulting fees from AbbVie, Arbutus, Antios, Eiger, Enanta, Gilead Sciences, GlaxoSmithKline, and Janssen and funds for research support from AbbVie, Alexion, Deep Genomics, Gilead Sciences, Eiger, Enanta, Finch, Janssen, and Wako/Fujifilm.

Nancy Reau, MD

Associate Professor of Medicine
Center for Liver Disease
University of Chicago
Chicago, Illinois

Nancy Reau, MD, has disclosed that she has received consulting fees from AbbVie, Arbutus, Antios, Gilead Sciences, Intercept and Salix and funds for research support from AbbVie, Eiger, and Gilead Sciences.